Biggest News Aggregation in the World
📰 Certain News

Page 140 - Certain News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Certain. Real-time updates on events, politics, business and more.

KEROS THERAPEUTICS, INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 31, 2022, Keros Therapeutics,... | January 31, 2022
Christopher Rovaldi Program Management Keros Therapeutics Inc Prior To Acceleron Pharma Inc Ns Biopharma Consulting Cubist Pharmaceuticals Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Merck & Co., Inc.: European Commission Approves Merck's KEYTRUDA (pembrolizumab) as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma (RCC) Following Surgery

KEYTRUDA Is Now Approved as Monotherapy for Adults With RCC at Increased Risk of Recurrence Following Nephrectomy, or Following Nephrectomy and Resection of Metastatic Lesions KEYTRUDA Is the First
United States Scot Ebbinghaus Peter Dannenbaum John Infanti Melissa Moody Damini Chokshi

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science